Biofrontera Inc. (NASDAQ:BFRIW – Get Free Report) was the target of a significant decrease in short interest in the month of July. As of July 31st, there was short interest totaling 2,578 shares, a decrease of 60.0% from the July 15th total of 6,447 shares. Based on an average daily volume of 5,485 shares, the short-interest ratio is currently 0.5 days.
Biofrontera Stock Up 6.9%
Shares of NASDAQ:BFRIW opened at $0.02 on Friday. Biofrontera has a 12-month low of $0.02 and a 12-month high of $0.19. The business has a fifty day simple moving average of $0.03 and a 200 day simple moving average of $0.04.
Biofrontera Company Profile
Biofrontera AG is a biopharmaceutical company headquartered in Leverkusen, Germany, specializing in the development, manufacture and commercialization of dermatology products. Founded in 1997, the company focuses on therapies for skin diseases through innovative drug and device combinations. Its core business centers on photodynamic therapy, where a photosensitizing agent is activated by a specialized light source to treat precancerous and cancerous skin conditions.
The company’s flagship product, Ameluz, is a topical formulation of aminolevulinic acid used in conjunction with the BF-RhodoLED irradiation device.
Featured Stories
- Five stocks we like better than Biofrontera
- Asian Market Circuit Breakers Hit Stocks, Not AI Demand
- Riot Platforms Re-Wires the Ledger for a $9B AI Power Play
- Nebius Just Exploded 34% on Blowout Earnings—Is It Time to Buy?
- Joby’s Defense Pivot Accelerates With $500M Resonant Sciences Deal
Receive News & Ratings for Biofrontera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biofrontera and related companies with MarketBeat.com's FREE daily email newsletter.
